Source: Eur Respir Rev, 29 (157) 200240; 10.1183/16000617.0240-2020
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Ricardo J. José, Andrew Williams, Ari Manuel, Jeremy S. Brown, Rachel C. Chambers. Targeting coagulation activation in severe COVID-19 pneumonia: lessons from bacterial pneumonia and sepsis. Eur Respir Rev, 29 (157) 200240; 10.1183/16000617.0240-2020

Member's Comments

No comment yet.

Related content which might interest you: The interconnection of severe pneumonia and sepsis Source: Eur Respir J 2004; 24: Suppl. 48, 548s Year: 2004 Characterization of community acquired pneumonia (CAP) with severe sepsis at diagnosis Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012 Initial and persistent inflammatory response in treatment failure in community-acquired pneumonia Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia Year: 2007 Corticosteroids in severe pneumonia Source: Eur Respir J 2008; 32: 259-264 Year: 2008 Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia Source: Eur Respir J 2009; 33: 153-159 Year: 2009 Estimation of inflammatory process activity in community-acquired pneumonia Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010 Macrophage activation in exacerbated COPD with and without community-acquired pneumonia Source: Eur Respir J 2010; 36: 285 Year: 2010 Respiratory infections in the immunocompetent host: from asthma exacerbations to hospital-acquired pneumonia Source: Annual Congress 2007 - Infections year in review Year: 2007 Regulation of neutrophilic inflammation in community acquired pneumonia Source: Lung Science Conference 2015 Year: 2015 Incidence of severe sepsis as a cause of clinical failure in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2007; 30: Suppl. 51, 42s Year: 2007 Acute respiratory failure and severe sepsis may identify different clinical phenotypes in community-acquired pneumonia Source: Annual Congress 2013 –Interesting research questions Year: 2013 Role of biomarkers of systemic inflammation in the prediction of mortality and/or severe complications in community adquired pneumonia Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019 Effects of glucocorticoids in ventilated piglets with severe pneumonia Source: Eur Respir J 2008; 32: 1037-1046 Year: 2008 Lung vessel thrombosis like the reason of mortality at severe community-acquired pneumonia (CAP) of viral and bacterial etiology - autopsy data Source: International Congress 2018 – Mechanisms of respiratory infection Year: 2018 Neutralizing the complement component C5a protects against lung injury and extrapulmonary organ injury in pneumococcal pneumonia induced sepsis Source: International Congress 2014 – Critical illness and therapeutic interventions Year: 2014 Features of systemic inflammation in patients with severe community-acquired (CAP) pneumonia of different etiology in HIV-infected patients Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015 Respiratory pathogens, immunodeficiency or systemic response – What comes first in the etiology of severe community-acquired pneumonia (sCAP) Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013 CD4 as a predictor of systemic inflammatory response and death at severe community-acquired pneumonia Source: Annual Congress 2013 –Interesting cases of respiratory infections Year: 2013